Seattle, WA (February 4, 2016) – Fenwick & West is pleased to announce that Stephen Graham, a partner at Fenwick & West LLP, has been reappointed co-chairman of the Securities and Exchange Commission’s Advisory Committee on Small and Emerging Companies.
Graham is co-chair of Fenwick’s life sciences practice and is managing partner of the firm’s Seattle office. He was first appointed to the advisory committee in 2011.
“We are proud of Steve's leadership of the SEC advisory committee and his focus on the issues facing the emerging companies that are such an important part of our economy,” said Richard Dickson, partner and chair of Fenwick.
Since the advisory committee was formed in 2011, it has been renewed twice. It is made up of 15 voting members and two non-voting members. The current group will hold its first meeting on February 25.
Graham and his fellow members will serve until September 24, 2017.
“Small businesses play a crucial role in our nation’s economy,” SEC Chair Mary Jo White said as the Commission appointed eleven new members and renewed the appointments of Graham and three others. “The advisory committee members have a wealth of experience and ideas that will help inform the Commission on the many important issues affecting small and emerging businesses.”
“I am honored to again be selected to lead this committee,” Graham said. “I look forward to continuing to serve our nation’s small business community and doing what I can to help ensure an environment in which small and emerging companies can thrive.”
At Fenwick, Graham concentrates on private and public mergers and acquisitions; public offerings; private placements; and corporate governance matters such as advising boards of directors and audit, compensation and nominating/corporate governance committees, preparation and filing of periodic SEC reports, and other securities law compliance.
His diverse practice focuses on the representation of emerging and established high growth companies, and essentially serving as an extension of the senior management teams and boards of directors. He has represented companies and investment banks in numerous initial public offerings, a wide variety of merger and acquisition transactions, and private offerings of debt and equity.
He has been recognized by Chambers USA as one of the top corporate and mergers and acquisitions lawyers in Washington. He has also earned several other accolades, including being recognized as a Life Sciences Star for his outstanding transactional work in Euromoney’s LMG Life Sciences 2012 and 2013. In December, the Washington Post named Graham among the 19 most influential people in Washington D.C. who can impact startups.
To learn more about the advisory committee, visit the SEC website.
About Fenwick & West
Fenwick & West provides comprehensive legal services to ground-breaking technology and life sciences companies – at every stage of their lifecycle – and the investors that partner with them. We craft innovative, cost-effective and practical solutions on issues ranging from venture capital, public offerings, joint ventures, M&A and strategic relationships, to intellectual property, litigation and dispute resolution, taxation, antitrust, and employment and labor law. For more than four decades, Fenwick has helped some of the world's most recognized companies become and remain market leaders. For information about a career at Fenwick visit us at fenwick.com/careers.